Twist Bioscience (TWST) Inventory Average (2018 - 2026)

Twist Bioscience (TWST) has reported Inventory Average for 9 consecutive years, with $34.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 46.75% year-over-year to $34.3 million in Q2 2026; TTM through Jun 2026 was $34.3 million, a 46.75% increase from a year earlier, with the FY2025 full-year figure at $26.2 million, down 6.69% from the prior year.
• Inventory Average was $34.3 million for Q2 2026 at Twist Bioscience, up from $33.2 million in the prior quarter.
• Over five years, Inventory Average peaked at $43.8 million in Q2 2022 and troughed at $22.2 million in Q1 2025.
• A 5-year average of $33.1 million and a median of $32.3 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 190.05% in 2022 and slipped 27.54% in 2024, its largest moves.
• Over 5 years, Inventory Average stood at $42.0 million in 2022, then slipped by 25.0% to $31.5 million in 2023, then slipped by 24.36% to $23.8 million in 2024, then increased by 28.65% to $30.6 million in 2025, then increased by 12.16% to $34.3 million in 2026.
• The last three Inventory Average figures came in at $34.3 million (Q2 2026), $33.2 million (Q1 2026), and $30.6 million (Q4 2025), per Business Quant data.